Category Archives: new treatments
Delayed fingolimod-associated asystole. [Mult Scler. 2011] – PubMed – NCBI
Mult Scler. 2011 Nov;17(11):1387-9. doi: 10.1177/1352458511410344. Epub 2011 Jun 7. Delayed fingolimod-associated asystole. Espinosa PS, Berger JR. Source North Oaks Neurology, Hammond, LA, USA. ps.espinosa@gmail.com Abstract Oral fingolimod (Gilenya) is a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from … Continue reading
The month of birth effect in m… [J Neurol Neurosurg Psychiatry. 2012] – PubMed – NCBI
J Neurol Neurosurg Psychiatry. 2012 Nov 14. [Epub ahead of print] The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. Dobson R, Giovannoni G, Ramagopalan S. Source Queen Mary University of London, Blizard Institute, … Continue reading
Curcuminoids in neurodegenerative… [Recent Pat CNS Drug Discov. 2012] – PubMed – NCBI
Recent Pat CNS Drug Discov. 2012 Dec;7(3):184-204. Curcuminoids in neurodegenerative diseases. Kim DS, Kim JY, Han Y. Source Core LifeSource Inc. 5100 Newport Dr. Suite # 10, Rolling Meadows, IL 60008, USA. calebin@gmail.com Abstract Neurodegeneration is a term used to … Continue reading
Vitamin D and multiple sclerosis: a critica… [Acta Neurol Belg. 2012] – PubMed – NCBI
Vitamin D and multiple sclerosis: a critica… [Acta Neurol Belg. 2012] – PubMed – NCBI. Acta Neurol Belg. 2012 Dec;112(4):327-33. doi: 10.1007/s13760-012-0108-z. Epub 2012 Jul 6. Vitamin D and multiple sclerosis: a critical review and recommendations on treatment. Faridar A, … Continue reading
Maurice Preter, MD
Maurice Preter, MD is a European and U.S. educated psychiatrist, psychotherapist, psychopharmacologist, neurologist, and medical-legal expert in private practice in Manhattan. He is also the principal of Fifth Avenue Concierge Medicine, PLLC, a medical concierge service and health advisory for select individuals and families.